George F. Geils, Jr., MD

Medical Oncology and Hematology Specialist

George F. Geils, Jr., MD is board-certified in Internal Medicine, Medical Oncology, and Hematology. Dr. Geils is the Medical Director for the Blood and Marrow Transplant Program for Roper St. Francis Healthcare. A graduate of the Medical University of South Carolina, he completed his residency at the University of Maryland Medical Center, and his fellowship at The University of Alabama at Birmingham in Hematology, Medical Oncology and Bone Marrow Transplantation.

Dr. Geils is a member of the American Society for Blood and Marrow Transplantation, International Society of Hematotherapy and Graft Engineering, American Medical Association, American College of Physicians, American Society of Hematology, American Society of Clinical Oncology, and various local and state professional organizations relating to his field. He serves as the Chairman of The Roper St. Frances Institutional Review Board, Chairman of the Roper St. Francis Pharmacy and Therapeutics Committee, and Member of the Roper Medical Executive Committee. Dr.

Geils has several published works in the Journal of Clinical Oncology and the Journal of Hematotherapy. He continues his research in allogeneic stem cell transplantation, alloimmune recovery, and cell-mediated graft-versus disease effect.

Choose your preferred location

West Ashley

North Charleston

Downtown

Summerville

Mt. Pleasant

Walterboro

Send UsA Message

LOCATION*

PROVIDER*

FIRST NAME*

LAST NAME*

EMAIL ADDRESS*

PHONE*

Birthdate*

MESSAGE

I understand and agree that any information submitted will be forwarded to our office by email and not via a secure messaging system. This form should not be used to transmit private health information, and we disclaim all warranties with respect to the privacy and confidentiality of any information submitted through this form.*

Early-Stage Breast Cancer Characteristics and Treatment Options

Sep 16, 2022

Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...

Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

Apr 7, 2022

Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”

Lowcountry doctors, patients helped secure ‘game-changer’ cancer treatment approval

Apr 7, 2022

Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.

Lowcountry Breast Cancer Survivors On Finding The Right Oncology Practice

Oct 25, 2021

How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.

Sarcoma and Bone Cancer Awareness

Sep 15, 2021

July is Sarcoma and Bone Cancer Awareness Month. Sarcomas are a rare group of cancers in which malignant cells form in the bones or soft tissues of the body.

May is Skin Cancer Awareness Month

May 26, 2021

Melanoma is a type of skin cancer that develops when melanocytes start to grow out of control. Watch a video to learn more about melanoma from Dr. Charles S. Holladay.

« Older Entries

Next Entries »